Taxane containing regimens for metastatic breast cancer-Reference-Cited by-同舟云学术

Taxane containing regimens for metastatic breast cancer

Published:2005-04-20 Issue: Volume: Page:
ISSN:
Container-title:Cochrane Database of Systematic Reviews
language:
Short-container-title:

Author:

Ghersi Davina,Wilcken Nicholas,Simes John,Donoghue Emma

Publisher

John Wiley & Sons, Ltd

Reference73 articles.

1. Docetaxel versus doxorubicin in patients with metastatic breast cancer who have failed alkylating chemotherapy: a preliminary report of the randomized phase III trial. 303 Study Group;Aapro,1998

2. Docetaxel vs doxorubicin in metastatic breast cancer resistant to alkylating chemotherapy;Chan;Oncology (Huntington),1997

3. Phase III study of taxotere vs doxorubicin in patients with metastatic breast cancer who have failed an alkylating containing regimen;Chan,1997

4. Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer. John Crown for the 303 Study Group;Chan;J Clin Oncol,1999

5. Docetaxel (Taxotere) vs doxorubicin in patients with metastic breast cancer (MBC) who have failed alkylating chemotherapy. Randomized multicenter phase III trial.;Chan,1997

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The progress of combination therapy with immune checkpoint inhibitors in breast cancer;BIOCELL;2023

2. A systematic review and meta-analysis of nab-paclitaxel mono-chemotherapy for metastatic breast cancer;BMC Cancer;2021-07-18

3. Taxanes for adjuvant treatment of early breast cancer;Cochrane Database of Systematic Reviews;2019-09-02

4. Effectiveness of taxanes over anthracyclines in neoadjuvant setting: A systematic-review and meta-analysis;World Journal of Meta-Analysis;2019-04-30

5. Disparities in Breast Cancer: Private Patients Have Better Outcomes Than Public Patients;World Journal of Surgery;2017-08-17